Showing results (1181-1190 of 1,370) with videos related to
Sort By:
Pageof 137
Journal of Cardiovascular Electrophysiology|October 7, 2009
Canadian Registry of ICD Implant Testing procedures (CREDIT): current practice, risks, and costs of intraoperative defibrillation testingJeff S Healey, Paul Dorian, L Brent Mitchell, et al.Cardiovascular Research|April 15, 2020
Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery diseaseYan Liang, Jun Zhu, Lisheng Liu, et al.European Journal of Preventive Cardiology|October 17, 2019
Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trialThomas Vanassche, Peter Verhamme, Sonia S Anand, et al.Circulation|December 6, 2006
Network analysis of human in-stent restenosisEuan A Ashley, Rossella Ferrara, Jennifer Y King, et al.Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonistsPaul Galatsis, Koji Yamagata, John A Wendt, et al.Stroke|June 11, 2020
Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source: NAVIGATE-ESUS TrialRobert Mikulík, Jens Eckstein, Lesly A Pearce, et al.Drug Testing and Analysis|December 1, 2023
Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5-bromo-indazole-3-carboxamide synthetic cannabinoid receptor agonistsCaitlyn Norman, Kristin Webling, Oleksandra Kyslychenko, et al.Bioorganic & Medicinal Chemistry Letters|May 8, 2007
4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: synthesis and biological evaluationTerry V Hughes, Stuart L Emanuel, Amanda K Beck, et al.Heart (British Cardiac Society)|May 22, 2021
Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery diseaseGilles R Dagenais, Leanne Dyal, Jacqueline J Bosch, et al.Journal of the National Cancer Institute|February 5, 2004
Workshop on partial breast irradiation: state of the art and the science, Bethesda, MD, December 8-10, 2002P Wallner, D Arthur, H Bartelink, et al.Pageof 137